{"id":"https://openalex.org/W2897909896","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","title":"SAT0370 Association of renal dysfunction and development of tophi in subjects with chronic refractory gout and response to treatment with pegloticase","display_name":"SAT0370 Association of renal dysfunction and development of tophi in subjects with chronic refractory gout and response to treatment with pegloticase","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2897909896","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","mag":"2897909896"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2018-eular.5666","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1049.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1049.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110907398","display_name":"N. Lawrence Edwards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N.L. Edwards","raw_affiliation_strings":["University of Florida, Gainesville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046999547","display_name":"Jasvinder A. Singh","orcid":"https://orcid.org/0000-0003-3485-0006","observed_orcids":["https://orcid.org/0000-0003-3485-0006"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Singh","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043219883","display_name":"Orrin M. Troum","orcid":"https://orcid.org/0009-0005-3956-0253","observed_orcids":["https://orcid.org/0009-0005-3956-0253"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. Troum","raw_affiliation_strings":["University of Southern California, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, Los Angeles","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001484726","display_name":"Anthony E. T. Yeo","orcid":"https://orcid.org/0000-0002-7907-6029","observed_orcids":["https://orcid.org/0000-0002-7907-6029"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Yeo","raw_affiliation_strings":["Horizon Pharma, Lake Forest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Horizon Pharma, Lake Forest","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043874873","display_name":"Peter E. Lipsky","orcid":"https://orcid.org/0000-0002-9287-1676","observed_orcids":["https://orcid.org/0000-0002-9287-1676"]},"institutions":[{"id":"https://openalex.org/I4210110460","display_name":"Ampel BioSolutions (United States)","ror":"https://ror.org/01z71je29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Lipsky","raw_affiliation_strings":["AMPEL BioSolutions LLC, Charlottesville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMPEL BioSolutions LLC, Charlottesville, USA","institution_ids":["https://openalex.org/I4210110460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":null,"first_page":"1049","last_page":"1049"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tophi","display_name":"tophi","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pegloticase","display_name":"pegloticase","score":0.9369999766349792},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8130000233650208},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/urate-oxidase","display_name":"uricase","score":0.6660000085830688},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.6669999957084656},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.7699999809265137},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9384210705757141},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.9000952243804932},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7871320247650146},{"id":"https://openalex.org/C2777385986","wikidata":"https://www.wikidata.org/wiki/Q2293277","display_name":"Tophus","level":4,"score":0.7672594785690308},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6522853374481201},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5127130746841431},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.501878023147583},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4694010317325592},{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.46158722043037415},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4563572406768799},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36192572116851807},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.34661710262298584},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.18355929851531982},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2018-eular.5666","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1049.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2018-eular.5666","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5666","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1049.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2897909896.pdf","grobid_xml":"https://content.openalex.org/works/W2897909896.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2922090796","https://openalex.org/W2755748659","https://openalex.org/W2756473263","https://openalex.org/W2907400028","https://openalex.org/W2134270035","https://openalex.org/W2125550109","https://openalex.org/W2410099191","https://openalex.org/W2910808554","https://openalex.org/W2286956807","https://openalex.org/W3039914719"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-10-26T00:00:00"}